BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8490053)

  • 1. A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.
    Tamamura H; Kuroda M; Masuda M; Otaka A; Funakoshi S; Nakashima H; Yamamoto N; Waki M; Matsumoto A; Lancelin JM
    Biochim Biophys Acta; 1993 May; 1163(2):209-16. PubMed ID: 8490053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II).
    Masuda M; Nakashima H; Ueda T; Naba H; Ikoma R; Otaka A; Terakawa Y; Tamamura H; Ibuka T; Murakami T
    Biochem Biophys Res Commun; 1992 Dec; 189(2):845-50. PubMed ID: 1472056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure.
    Tamamura H; Waki M; Imai M; Otaka A; Ibuka T; Waki K; Miyamoto K; Matsumoto A; Murakami T; Nakashima H; Yamamoto N; Fujii N
    Bioorg Med Chem; 1998 Apr; 6(4):473-9. PubMed ID: 9597190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
    Nakashima H; Masuda M; Murakami T; Koyanagi Y; Matsumoto A; Fujii N; Yamamoto N
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1249-55. PubMed ID: 1384424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).
    Tamamura H; Arakaki R; Funakoshi H; Imai M; Otaka A; Ibuka T; Nakashima H; Murakami T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Bioorg Med Chem; 1998 Feb; 6(2):231-8. PubMed ID: 9547946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptide, tachyplesin I, isolated from hemocytes of the horseshoe crab (Tachypleus tridentatus). NMR determination of the beta-sheet structure.
    Kawano K; Yoneya T; Miyata T; Yoshikawa K; Tokunaga F; Terada Y; Iwanaga S
    J Biol Chem; 1990 Sep; 265(26):15365-7. PubMed ID: 2394727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).
    Otaka A; Tamamura H; Terakawa Y; Masuda M; Koide T; Murakami T; Nakashima H; Matsuzaki K; Miyajima K; Ibuka T
    Biol Pharm Bull; 1994 Dec; 17(12):1669-72. PubMed ID: 7735216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of an anti-HIV peptide, T22.
    Tamamura H; Murakami T; Masuda M; Otaka A; Takada W; Ibuka T; Nakashima H; Waki M; Matsumoto A; Yamamoto N
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1729-35. PubMed ID: 7811258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule.
    Weeks BS; Nomizu M; Otaka A; Weston CA; Okusu A; Tamamura H; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1995 Oct; 215(2):626-31. PubMed ID: 7488001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection.
    Tamamura H; Imai M; Ishihara T; Masuda M; Funakoshi H; Oyake H; Murakami T; Arakaki R; Nakashima H; Otaka A; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Bioorg Med Chem; 1998 Jul; 6(7):1033-41. PubMed ID: 9730240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.
    Miyata T; Tokunaga F; Yoneya T; Yoshikawa K; Iwanaga S; Niwa M; Takao T; Shimonishi Y
    J Biochem; 1989 Oct; 106(4):663-8. PubMed ID: 2514185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4.
    Xu Y; Tamamura H; Arakaki R; Nakashima H; Zhang X; Fujii N; Uchiyama T; Hattori T
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):419-27. PubMed ID: 10195751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anti-HIV peptide, T22, forms a highly active complex with Zn(II).
    Tamamura H; Otaka A; Murakami T; Ibuka T; Sakano K; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Dec; 229(2):648-52. PubMed ID: 8954952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives.
    Laederach A; Andreotti AH; Fulton DB
    Biochemistry; 2002 Oct; 41(41):12359-68. PubMed ID: 12369825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new tachyplesin, tachyplesin III, and a processing intermediate of its precursor.
    Muta T; Fujimoto T; Nakajima H; Iwanaga S
    J Biochem; 1990 Aug; 108(2):261-6. PubMed ID: 2229025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds.
    Rao AG
    Arch Biochem Biophys; 1999 Jan; 361(1):127-34. PubMed ID: 9882437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
    Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
    Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance.
    Tamamura H; Ishihara T; Otaka A; Murakami T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochim Biophys Acta; 1996 Nov; 1298(1):37-44. PubMed ID: 8948487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices.
    Park NG; Lee S; Oishi O; Aoyagi H; Iwanaga S; Yamashita S; Ohno M
    Biochemistry; 1992 Dec; 31(48):12241-7. PubMed ID: 1457421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.